1. Home
  2. ALLK vs FSHP Comparison

ALLK vs FSHP Comparison

Compare ALLK & FSHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLK
  • FSHP
  • Stock Information
  • Founded
  • ALLK 2012
  • FSHP 2018
  • Country
  • ALLK United States
  • FSHP United States
  • Employees
  • ALLK N/A
  • FSHP N/A
  • Industry
  • ALLK Biotechnology: Pharmaceutical Preparations
  • FSHP
  • Sector
  • ALLK Health Care
  • FSHP
  • Exchange
  • ALLK Nasdaq
  • FSHP NYSE
  • Market Cap
  • ALLK 101.0M
  • FSHP 89.2M
  • IPO Year
  • ALLK 2018
  • FSHP 2024
  • Fundamental
  • Price
  • ALLK $1.10
  • FSHP $10.15
  • Analyst Decision
  • ALLK Hold
  • FSHP
  • Analyst Count
  • ALLK 5
  • FSHP 0
  • Target Price
  • ALLK $1.67
  • FSHP N/A
  • AVG Volume (30 Days)
  • ALLK 306.2K
  • FSHP 35.0K
  • Earning Date
  • ALLK 11-06-2024
  • FSHP 01-01-0001
  • Dividend Yield
  • ALLK N/A
  • FSHP N/A
  • EPS Growth
  • ALLK N/A
  • FSHP N/A
  • EPS
  • ALLK N/A
  • FSHP 0.11
  • Revenue
  • ALLK N/A
  • FSHP N/A
  • Revenue This Year
  • ALLK N/A
  • FSHP N/A
  • Revenue Next Year
  • ALLK N/A
  • FSHP N/A
  • P/E Ratio
  • ALLK N/A
  • FSHP $89.28
  • Revenue Growth
  • ALLK N/A
  • FSHP N/A
  • 52 Week Low
  • ALLK $0.54
  • FSHP $9.99
  • 52 Week High
  • ALLK $3.36
  • FSHP $10.16
  • Technical
  • Relative Strength Index (RSI)
  • ALLK 52.99
  • FSHP N/A
  • Support Level
  • ALLK $1.00
  • FSHP N/A
  • Resistance Level
  • ALLK $1.11
  • FSHP N/A
  • Average True Range (ATR)
  • ALLK 0.08
  • FSHP 0.00
  • MACD
  • ALLK 0.00
  • FSHP 0.00
  • Stochastic Oscillator
  • ALLK 47.73
  • FSHP 0.00

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

About FSHP FLAG SHIP ACQUISITION CORPORATION

Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: